However, in 2020, a study by Williamson et al. highlighted that certain heterozygous PAX6 missense variants can cause clinical manifestations that are more severe than aniridia (including microphthalmia and anophthalmia) [6]. This evidence concerns the gene PAX6 and aniridia.